Comparative Analysis of Different DNA-Binding Drugs for Leishmaniasis Cure: A Pharmacoinformatics Approach.

Authors:
Address: Department of Biotechnology, Birla Institute of Technology, Mesra, Ranchi, Jharkhand 835215, India.
Journal:

Publication:

abstract

Several experiments have been performed to test DNA-Binding Drugs to Cure Leishmania infection. However, there are no details of Pharmacoinformatics study. Herein, we have selected a good number of compounds from experimentally verified studies and performed a Comparative Analysis based on pharmacoinformatics techniques. In silico docking study was performed to observe the molecular level interactions of these known ligands with the DNA receptor by automated computational docking using Glide. A comparison between the calculated interaction energies and in silico ADME/T study was made. In agreement with drug likeness rules, our study suggests that seco-hydroxy-aza-CBI-TMI (compound 4b; GScore, -12.058) is a potential molecule for targeting the DNA to cure Leishmaniasis.

Related Articles
A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties.
Bioorg Med Chem. 2004
A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties.
Kupchinsky S, Centioni S, Howard T, Trzupek J, Roller S, Carnahan V, Townes H, Purnell B, Price C, Handl H, et al. Bioorg Med Chem. 2004 Dec 1; 12(23):6221-36.
Homology modeling and atomic level binding study of Leishmania MAPK with inhibitors.
J Mol Model. 2010
Homology modeling and atomic level binding study of Leishmania MAPK with inhibitors.
Awale M, Kumar V, Saravanan P, Mohan CG. J Mol Model. 2010 Mar; 16(3):475-88. Epub 2009 Aug 2.
In silico studies on marine actinomycetes as potential inhibitors for Glioblastoma multiforme.
Bioinformation. 2011
In silico studies on marine actinomycetes as potential inhibitors for Glioblastoma multiforme.
Kirubakaran P, Kothapalli R, Singh KhD, Nagamani S, Arjunan S, Muthusamy K. Bioinformation. 2011 Apr 22; 6(3):100-6. Epub 2011 Apr 22.
Review Importance of molecular computer modeling in anticancer drug development.
J BUON. 2007
Review Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD. J BUON. 2007 Sep; 12 Suppl 1:S101-18.
Review Receptor-based computational screening of compound databases: the main docking-scoring engines.
Curr Protein Pept Sci. 2006
Review Receptor-based computational screening of compound databases: the main docking-scoring engines.
Sperandio O, Miteva MA, Delfaud F, Villoutreix BO. Curr Protein Pept Sci. 2006 Oct; 7(5):369-93.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.